NEW HIV VACCINE KILLS 99% OF VIRUS ON FIRST HUMAN TRIAL

0

A new HIV drug created by Israeli researchers has passed its first human clinical trial.

At end of the trial, it was discovered that the drug, named Gammora, created by Zion Medical, an Israeli biotech company was capable of wiping out 99 per cent of HIV infected cells in the human body.

According to a statement released by the company and available on PR Newswire, Gammora was able to eliminate up to 90 per cent of the virus during the first four weeks of the trial.

Zion Medical developed the drug Gammora in collaboration with the Hebrew University in Jerusalem and the Sirion Biotech in Germany.

In the study, researchers randomly assigned nine participating patients from the Ronald Bata Memorial Hospital in Uganda to receive different doses of Gammora between four to five weeks in July and August of this year.

“Most patients showed a significant reduction of the viral load of up to 90 per cent from the baseline during the first four weeks,” said Dr. Esmira Naftalim, Zion Medical’s head of development.(HOWAFRICA)

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Comment moderation is enabled. Your comment may take some time to appear.

This site uses Akismet to reduce spam. Learn how your comment data is processed.